Maria V. Savvateeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria V. Savvateeva has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alexander L. Golovyuk
Vascular Surgery Department, A. V. Vishnevsky National Medical Research Center of Surgery, 27, Bolshaya Serpukhovskaya Street, 117997 Moscow, Russia
1 shared publication - Alexey Alexandrovich Dmitriev
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
1 shared publication - Anastasiya V. Snezhkina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
1 shared publication - Andrey A. Poloznikov
Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia
1 shared publication - Anna Viktorovna Kudryavtseva
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia
1 shared publication - Dmitry Valerievich Kalinin
A.V. Vishnevsky National Medical Research Center of Surgery
1 shared publication
Latest Publications
- Open Access
- 22 September 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (18) , 6950
Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas
Carotid paragangliomas (CPGLs) are rare neuroendocrine tumors often associated with mutations in SDHx genes. The immunohistochemistry of succinate dehydrogenase (SDH) subunits has been considered a useful instrument for the prediction of SDHx mutations in paragangliomas/pheochromocytomas. We compared the mutation status of SDHx genes with the immunohistochemical (IHC) staining of SDH subunits in CPGLs. To identify pathogenic/likely pathogenic variants in SDHx genes, exome sequencing data analysis among 42 CPGL patients was performed. IHC staining of SDH subunits was carried out for all CPGLs studied. We encountered SDHx variants in 38% (16/42) of the cases in SDHx genes. IHC showed negative (5/15) or weak diffuse (10/15) SDHB staining in most tumors with variants in any of SDHx (94%, 15/16). In SDHA-mutated CPGL, SDHA expression was completely absent and weak diffuse SDHB staining was detected. Positive immunoreactivity for all SDH subunits was found in one case with a variant in SDHD. Notably, CPGL samples without variants in SDHx also demonstrated negative (2/11) or weak diffuse (9/11) SDHB staining (42%, 11/26). Obtained results indicate that SDH immunohistochemistry does not fully reflect the presence of mutations in the genes; diagnostic effectiveness of this method was 71%. However, given the high sensitivity of SDHB immunohistochemistry, it could be used for initial identifications of patients potentially carrying SDHx mutations for recommendation of genetic testing.
- 22 September 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (18) , 6950
Open AccessImmunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas
Carotid paragangliomas (CPGLs) are rare neuroendocrine tumors often associated with mutations in SDHx genes. The immunohistochemistry of succinate dehydrogenase (SDH) subunits has been considered a useful instrument for the prediction of SDHx mutations in paragangliomas/pheochromocytomas. We compared the mutation status of SDHx genes with the immunohistochemical (IHC) staining of SDH subunits in CPGLs. To identify pathogenic/likely pathogenic variants in SDHx genes, exome sequencing data analysis among 42 CPGL patients was performed. IHC staining of SDH subunits was carried out for all CPGLs studied. We encountered SDHx variants in 38% (16/42) of the cases in SDHx genes. IHC showed negative (5/15) or weak diffuse (10/15) SDHB staining in most tumors with variants in any of SDHx (94%, 15/16). In SDHA-mutated CPGL, SDHA expression was completely absent and weak diffuse SDHB staining was detected. Positive immunoreactivity for all SDH subunits was found in one case with a variant in SDHD. Notably, CPGL samples without variants in SDHx also demonstrated negative (2/11) or weak diffuse (9/11) SDHB staining (42%, 11/26). Obtained results indicate that SDH immunohistochemistry does not fully reflect the presence of mutations in the genes; diagnostic effectiveness of this method was 71%. However, given the high sensitivity of SDHB immunohistochemistry, it could be used for initial identifications of patients potentially carrying SDHx mutations for recommendation of genetic testing.